Jennifer Palacios

Drug development in rare diseases requires the most efficient use of limited data, across both clinical trials and real-world settings. In this webinar, we will explore how combining predictive disease and care modeling with real-world data (RWD) can help translate efficacy observed in clinical trials into real-world effectiveness.  Using practical examples from rare disease settings, […]

About This Webinar Bayesian methods continue to gain momentum as an alternative approach to traditional clinical trial design, yet many organizations still have limited experience applying them, particularly when engaging with regulators. With multiple global agencies releasing further guidance in this area, it is useful to understand the current landscape of this trial area. In […]

About This Webinar In this session, we explore real-world use cases where AI and LLMs (Large Language Models) have been applied to explore large data sources such as omics, literature, and real-world data (RWD). We explore how AI can help identify optimal target populations, endpoints, and even support drug repurposing. Speaker: Billy Amzal, Ph.D.Head of […]

About This Webinar Drug development in rare diseases requires the most efficient use of limited data, across both clinical trials and real-world settings. In this webinar, we will explore how combining predictive disease and care modeling with real-world data (RWD) can help translate efficacy observed in clinical trials into real-world effectiveness.  Using practical examples from […]

Join us for a transformative three-part webinar series, “Driving Clinical Research with AI,” where industry leaders will discuss groundbreaking advancements in AI and its impact on clinical research. Hosted by Billy Amzal, Ph.D. , he will be joined by other Phastar speakers and prominent industry experts.  This series will explore three key areas where AI is […]

About This Webinar As expectations for robust, real-world evidence continue to grow, understanding how regulators evaluate causal analyses is becoming increasingly important. In this session, we will explore why causality matters, how agencies such as the FDA, EMA, and NICE are viewing causal inference, and what this means for study design and regulatory submissions. Speakers […]

This webinar will cover methods that are crucial to making informed decisions. Specifically, personalized care through causal and federated learning, targeted maximum likelihood estimation (TMLE) and doubly robust methods.   Speakers: Ryan Batten, Senior Statistician, Phastar Julie Joss, Senior Researcher, Inria Josh Enxing, Senior Programmer, Phastar- Moderator Learning Points: Distinguishing correlation from causation in the […]

Phastar is excited to be attending BIO International, 22 – 25 June in San Diego, CA Visit us at booth #5957 to learn more about our solutions.

We are excited to be attending the ACDM AI Symposium in Dublin this year from Wednesday, 23 June to Wednesday 25 June. Schedule a meeting below to connect with our team:

We are excited to be presenting at PharmaSUG in Shanghai, 24-25 July 2026 Design and Analysis of a Multi-Frequency PRO Collection Strategy in a Clinical TrialJiaqi Lu, Programmer III

Phastar is delighted to be attending JSM 2026, 1-6 August in Boston, MA Connect to meet with our team on site or join our presentation: Twenty-Five Years of Oncology Clinical Trials: Design, Reporting, and Evidence Generation Trends Beth McDougall, Senior Statistician I3 August 2026, 8:30 – 8:45 am

Phastar is exhibiting at Medidata NEXT, 3 September 2026 in Shanghai, China Connect to meet with our team on site or stop by our exhibit.

Phastar is excited to be attending the RSS 2026, 7-10 September in Bournemouth, UK. Connect with us to learn more about our solutions.

Phastar is excited to be attending the ASA Biopharmaceutical Section Regulatory-Industry Statistics Workshop from 16 -18 September in Rockville, MD. Connect with us or visit booth #13 to learn more about our solutions.

Phastar is delighted to be attending ISCB GMDS, 27 September – 1 October in Freiburg, Germany Connect to meet with our team on site or visit our posters: RECIST oncology measurement error: an alternative sensitivity analysis to assess potential within-BICR measurement error (Id=475)Alexandra Hunt, Statistician III Bayesian Systematic ReviewChristina Geyer, Consultant Statistician

Phastar is delighted to be exhibiting at ConSPIC 2026, 8-10 October in Coimbatore, India. Visit the Phastar team at our exhibit and find out more about our solutions.

Phastar is excited to be attending OCT New England, 27 -28 October in Boston, MA. Connect with us or visit at booth #33A to learn more about our solutions.

Phastar is sponsoring BBSW 2026, 5-6 November in Foster City, CA. Connect below to set-up a meeting or stop by our exhibit.

Phastar is excited to be attending European Statistical Forum, 12 – 13 November in NH Budapest City, Budapest. Connect with us at our presentation or request a meeting below: Experiences of Utilizing the BOIN12 Method for Designing Rare/Small Population Oncology TrialsGiles Partington, Consultant Statistician13 November 2026

Phastar is excited to be attending PHUSE EU Connect, 15 – 18 November in Glasgow, Scotland Connect with us or visit our booth to learn more about our solutions. Posters: From Randomised Controlled Trials (RCTs) to Real-world Evidence (RE) Studies: Statistical Challenges and Solutions to Consider in Studies using Real-world Data (RD)Helen Marshall, Principal Statistician […]